Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul-Aug;76(4):499-509.
doi: 10.1590/S1808-86942010000400015.

Intratympanic methylprednisolone as rescue therapy in sudden sensorineural hearing loss

[Article in English, Portuguese]
Igor Teixeira Raymundo  1 , Fayez Bahmad Jr, Jairo Barros Filho, Thaís Gonçalves Pinheiro, Nilda Agostinho Maia, Carlos Augusto Oliveira
Affiliations

Intratympanic methylprednisolone as rescue therapy in sudden sensorineural hearing loss

[Article in English, Portuguese]
Igor Teixeira Raymundo et al. Braz J Otorhinolaryngol. 2010 Jul-Aug.

Abstract

Treatment in sudden sensorineural hearing loss is a contentious issue, today, oral steroids are the most common choice and considered the best treatment option, but the use of intratympanic steroids has become an attractive alternative, especially in cases when systemic therapy fails, or to avoid the side effects of the systemic use of steroids.

Aim: To describe the results of intratympanic methylprednisolone in idiopathic sudden sensorineural hearing loss after failure of oral prednisolone.

Methods: In a prospective study fourteen patients with idiopathic sudden sensorineural hearing loss were treated with intratympanic methylprednisolone after failing in the treatment with systemic steroids. Pretreatment and post-treatment audiometric evaluations including pure tone average (PTA) and speech reception thresholds (SRT) were analyzed.

Results: Ten from 14 patients treated with intra-tympanic methylprednisolone presented with hearing recovery > 20 dB in PTA or 20% in SRT.

Conclusion: Three intratympanic injections of methylprednisolone improved pure-tone average or speech discrimination scores for a subset of sudden hearing loss subjects that failed to benefit from oral steroids.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Recovery after oral corticosteroid therapy.
Figure 2
Figure 2
Recovery ratio following intratympanic corticosteroid therapy and the initial tritonal mean.
Figure 3
Figure 3
Recovery ratio following intratympanic corticosteroid therapy and the time elapsed before starting corticosteroid therapy.
Figure 4
Figure 4
Comparison between recovery and types of treatment.
Figure 5
Figure 5
Comparison between recovery of the SRR after oral and intratympanic corticosteroid therapy
See this image and copyright information in PMC

References

    1. Wilson WR, Byl FM, Laird N. The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double- blind clinical study. Arch Otolaryngol. 1980;106:772–776. - PubMed
    1. Byl FM., Jr. Sudden hearing loss: eight years' experience and suggested prognostic table. Laryngoscope. 1984;94:647–661. - PubMed
    1. Chen CY, Halpin C, Rauch SD. Oral steroid treatment of sudden sensorineural hearing loss: a ten year retrospective analysis. Otol Neurotol. 2003;24:728–733. - PubMed
    1. Mattox DE, Simmons FB. Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1977;86:463–480. - PubMed
    1. Zadeh MH, Storper IS, Spitzer JB. Diagnosis and treatment of sudden-onset sensorineural hearing loss: a study of 51 patients. Otolaryngol Head Neck Surg. 2003;128:92–98. - PubMed